Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: The risk factors associated with post-transplantation BKPyV nephropathy and BKPyV DNAemia: a prospective study in kidney transplant recipients

Fig. 3

BKPyV DNA levels in plasma for viremic patients. A. BKPyV DNA levels at six prescheduled time points in the FAS cohort, where non-BKPyVAN (n = 42, blue) and BKPyVAN (n = 10, red) are indicated. B. BKPyV DNA levels at six prescheduled time points in the PP cohort, where non-BKPyVAN (n = 34, blue) and BKPyVAN (n = 10, red) are indicated. C. Virological course of seven patients with high-level of BKPyV DNAemia for > 3 months. D. Virological course of 26 patients with high-level of BKPyV DNAemia for < 3 months. E. Virological course of 19 patients with low-level of BKPyV DNAemia. F. Time when peak BKPyV DNAemia occurred for the virological courses and endpoint diagnosis. Abbreviations: High-level DNAemia (HL), Lowest Level of Quantitative Determination (LLQD) and Limit of Detection (LoD) are indicated by dotted lines, whereas median values are indicated by black lines. Statistical significance was determined by multiple Mann-Whitney U tests with Holm-Sidak correction and is indicated on top when observed

Back to article page